Welcome to LookChem.com Sign In|Join Free
  • or
methyl 4-(3-nitrophenoxy)benzoate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

174666-18-3

Post Buying Request

174666-18-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

174666-18-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 174666-18-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,4,6,6 and 6 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 174666-18:
(8*1)+(7*7)+(6*4)+(5*6)+(4*6)+(3*6)+(2*1)+(1*8)=163
163 % 10 = 3
So 174666-18-3 is a valid CAS Registry Number.

174666-18-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(3-nitro-phenoxy)-benzoic acid methyl ester

1.2 Other means of identification

Product number -
Other names 4-(3-Nitro-phenoxy)-benzoesaeure-methylester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:174666-18-3 SDS

174666-18-3Relevant academic research and scientific papers

Diarylether inhibitors of farnesyl-protein transferase

Dinsmore, Christopher J.,Williams, Theresa M.,Hamilton, Kelly,O'Neill, Timothy J.,Rands, Elaine,Koblan, Kenneth S.,Kohl, Nancy E.,Gibbs, Jackson B.,Graham, Samuel L.,Hartman, George D.,Oliff, Allen I.

, p. 1345 - 1348 (1997)

The design and synthesis of simple nonpeptide inhibitors of farnesyl-protein transferase (FTase) are described. Cysteine-derived diarylether frameworks are appropriate structural replacements for the C-terminal tetrapeptide portion of the Ras protein, and possess in vitro potency against FTase. Inhibitory activity is dependent on the ring-substitution pattern, and does not require the presence of a C-terminal carboxylate group.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 174666-18-3